Biotechnology
The Biotechnology industry has a total of 589 stocks, with a combined market cap of $1.22 trillion and total revenue of $115.82 billion.
Market Cap
1.22T
Revenue
115.82B
Profits
-36.06B
PE Ratio
n/a
Profit Margin
-31.14%
Dividend Yield
0.04%
589 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 127.73B | -0.33% | 89,403 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 78.45B | 0.01% | 1,807,726 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 73.32B | -1.06% | 27,039 | 15.53B |
| 4 | ARGX | argenx SE | 51.74B | -11.85% | 344,975 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 41.37B | -3.92% | 165,504 | - |
| 6 | ONC | BeOne Medicines AG | 39.63B | -4.26% | 54,286 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 32.38B | -0.78% | 155,983 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.63B | -1.33% | 70,151 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 24.82B | -1.14% | 136,065 | 7.53M |
| 10 | BNTX | BioNTech SE | 23.42B | -2.10% | 113,281 | 3.03B |
| 11 | INCY | Incyte Corporation | 22.79B | -0.87% | 84,418 | 5.82B |
| 12 | GMAB | Genmab A/S | 21.62B | -2.80% | 500,480 | 4.13B |
| 13 | INSM | Insmed Incorporated | 21.40B | -3.66% | 252,535 | 1.14B |
| 14 | ASND | Ascendis Pharma A/S | 14.90B | -0.68% | 22,058 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.64B | -2.46% | 73,405 | 4.60B |
| 16 | EXEL | Exelixis, Inc. | 14.46B | -0.15% | 90,609 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.62B | -5.13% | 693,447 | - |
| 18 | BBIO | BridgeBio Pharma, Inc. | 12.87B | -0.97% | 125,675 | 713.07M |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.70B | -1.75% | 26,522 | 830.81M |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.37B | -1.63% | 125,194 | 1.66B |
| 21 | TECH | Bio-Techne Corporation | 11.37B | - | 291,382 | 1.22B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.21B | -0.56% | 9,273 | 1.28B |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.59B | -0.87% | 49,061 | 3.41B |
| 24 | IBRX | ImmunityBio, Inc. | 10.22B | -1.08% | 666,397 | 165.79M |
| 25 | PCVX | Vaxcyte, Inc. | 9.94B | -0.22% | 233,064 | - |
| 26 | KRYS | Krystal Biotech, Inc. | 9.61B | 0.04% | 11,371 | 440.48M |
| 27 | TWST | Twist Bioscience Corporation | 9.28B | -4.91% | 614,297 | 431.80M |
| 28 | PTGX | Protagonist Therapeutics, Inc. | 9.05B | -0.70% | 38,651 | 281.99M |
| 29 | AXSM | Axsome Therapeutics, Inc. | 8.95B | -1.21% | 77,420 | 776.57M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 8.81B | -2.24% | 78,120 | 105.00M |
| 31 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.58B | -1.19% | 48,945 | 669.50M |
| 32 | CYTK | Cytokinetics, Incorporated | 8.42B | -0.89% | 45,058 | 67.67M |
| 33 | PRAX | Praxis Precision Medicines, Inc. | 7.59B | -2.28% | 40,304 | 7.46M |
| 34 | ABVX | ABIVAX Société Anonyme | 7.53B | -1.85% | 145,145 | 5.33M |
| 35 | TGTX | TG Therapeutics, Inc. | 7.48B | -0.45% | 91,606 | 799.54M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 7.47B | -1.19% | 51,852 | - |
| 37 | CAI | Caris Life Sciences, Inc. | 7.40B | -3.43% | 182,953 | 989.61M |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.30B | -0.59% | 91,570 | 874.09M |
| 39 | IMVT | Immunovant, Inc. | 6.48B | -2.03% | 83,403 | - |
| 40 | BLTE | Belite Bio, Inc | 6.23B | -0.92% | 9,036 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.20B | 1.84% | 176,229 | 239.92M |
| 42 | IOVA | Iovance Biotherapeutics, Inc. | 5.88B | 0.50% | 1,142,766 | 324.97M |
| 43 | LGND | Ligand Pharmaceuticals Incorporated | 5.81B | -0.59% | 8,403 | 290.54M |
| 44 | KOD | Kodiak Sciences Inc. | 5.70B | -0.24% | 44,603 | - |
| 45 | CGON | CG Oncology, Inc. | 5.49B | -0.77% | 51,227 | 6.23M |
| 46 | MANE | Veradermics, Incorporated | 5.31B | 14.45% | 396,581 | - |
| 47 | ORKA | Oruka Therapeutics, Inc. | 5.24B | -0.50% | 25,715 | - |
| 48 | PTCT | PTC Therapeutics, Inc. | 5.20B | -1.38% | 44,661 | 1.01B |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 5.19B | -0.83% | 15,600 | 618.07M |
| 50 | CRSP | CRISPR Therapeutics AG | 5.13B | 1.40% | 332,392 | 13.39M |
| 51 | COGT | Cogent Biosciences, Inc. | 5.10B | -2.46% | 50,916 | - |
| 52 | SRRK | Scholar Rock Holding Corporation | 5.05B | -1.82% | 119,814 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 4.95B | -1.82% | 53,055 | 591.33M |
| 54 | ERAS | Erasca, Inc. | 4.92B | -0.42% | 126,542 | - |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.69B | -1.12% | 25,225 | 1.90M |
| 56 | DFTX | Definium Therapeutics, Inc. | 4.63B | -1.82% | 115,804 | - |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.22B | -1.87% | 48,906 | - |
| 58 | ABCL | AbCellera Biologics Inc. | 4.00B | -3.90% | 707,666 | 66.17M |
| 59 | RLAY | Relay Therapeutics, Inc. | 3.87B | -1.62% | 137,434 | 10.35M |
| 60 | TLX | Telix Pharmaceuticals Limited | 3.71B | -1.08% | 29,839 | 890.79M |
| 61 | TNGX | Tango Therapeutics, Inc. | 3.63B | -1.28% | 48,508 | 53.81M |
| 62 | LEGN | Legend Biotech Corporation | 3.58B | -3.24% | 112,182 | 1.27B |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.47B | -1.68% | 57,450 | 7.50M |
| 64 | IDYA | IDEAYA Biosciences, Inc. | 3.45B | -1.48% | 10,225 | 234.13M |
| 65 | PBLS | Parabilis Medicines, Inc. | 3.40B | -4.58% | 69,789 | 148.00K |
| 66 | ACAD | Acadia Pharmaceuticals Inc. | 3.38B | -0.20% | 55,145 | 1.14B |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.23B | -2.89% | 936,981 | - |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.22B | -0.24% | 9,168 | 606.33M |
| 69 | CELC | Celcuity Inc. | 3.16B | -1.72% | 81,137 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.04B | -2.65% | 94,405 | 117.00M |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 2.99B | -1.61% | 75,820 | 463.98M |
| 72 | DNLI | Denali Therapeutics Inc. | 2.98B | -2.71% | 63,582 | 3.60M |
| 73 | ELVN | Enliven Therapeutics, Inc. | 2.97B | -2.13% | 23,811 | - |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.93B | -1.69% | 205,878 | - |
| 75 | ZLAB | Zai Lab Limited | 2.70B | -4.98% | 54,239 | 449.61M |
| 76 | PGEN | Precigen, Inc. | 2.69B | -0.40% | 130,362 | 85.72M |
| 77 | MBX | MBX Biosciences, Inc. | 2.57B | -2.15% | 13,643 | - |
| 78 | NAMS | NewAmsterdam Pharma Company N.V. | 2.55B | -3.43% | 93,223 | 7.12M |
| 79 | BEAM | Beam Therapeutics Inc. | 2.43B | -1.94% | 104,804 | 156.04M |
| 80 | CLDX | Celldex Therapeutics, Inc. | 2.32B | -2.79% | 93,705 | 158.00K |
| 81 | IRON | Disc Medicine, Inc. | 2.29B | -2.42% | 49,996 | - |
| 82 | ADMA | ADMA Biologics, Inc. | 2.28B | 0.59% | 69,044 | 512.28M |
| 83 | NRIX | Nurix Therapeutics, Inc. | 2.28B | -3.34% | 88,550 | 36.77M |
| 84 | HRMY | Harmony Biosciences Holdings, Inc. | 2.28B | -0.65% | 25,045 | 959.90M |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.22B | -3.01% | 430,262 | - |
| 86 | PHVS | Pharvaris N.V. | 2.18B | -1.78% | 88,672 | - |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.15B | -6.32% | 4,783,352 | 54.86M |
| 88 | IMNM | Immunome, Inc. | 2.13B | -1.75% | 73,781 | 4.02M |
| 89 | VERA | Vera Therapeutics, Inc. | 2.11B | -3.01% | 53,893 | - |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | -0.81% | 33,560 | 311.51M |
| 91 | VCEL | Vericel Corporation | 2.06B | -1.35% | 30,112 | 306.30M |
| 92 | VRDN | Viridian Therapeutics, Inc. | 2.05B | -0.98% | 37,992 | 71.13M |
| 93 | ADRX | ADARx Pharmaceuticals, Inc. | 1.90B | -1.90% | 14,206 | 6.13M |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 1.90B | -2.49% | 149,537 | - |
| 95 | URGN | UroGen Pharma Ltd. | 1.90B | -4.55% | 73,071 | 188.73M |
| 96 | FTRE | Fortrea Holdings Inc. | 1.90B | -2.92% | 40,037 | 2.68B |
| 97 | LKFT | Lakefront Biotherapeutics NV | 1.89B | -1.93% | 164,541 | 1.13B |
| 98 | VIR | Vir Biotechnology, Inc. | 1.89B | -3.08% | 140,373 | 303.23M |
| 99 | GPCR | Structure Therapeutics Inc. | 1.88B | -1.09% | 57,727 | - |
| 100 | PVLA | Palvella Therapeutics, Inc. | 1.88B | -0.18% | 32,002 | - |
| 101 | AGIO | Agios Pharmaceuticals, Inc. | 1.88B | -1.20% | 11,929 | 98.34M |
| 102 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.85B | -4.04% | 236,911 | 208.78M |
| 103 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | - | 90,096 | 1.97B |
| 104 | ZYME | Zymeworks Inc. | 1.84B | -2.53% | 23,749 | 37.13M |
| 105 | TRVI | Trevi Therapeutics, Inc. | 1.82B | -2.63% | 79,637 | - |
| 106 | NVAX | Novavax, Inc. | 1.81B | -1.96% | 509,013 | 413.80M |
| 107 | ZBIO | Zenas BioPharma, Inc. | 1.77B | -3.48% | 16,151 | 1.00M |
| 108 | BHVN | Biohaven Ltd. | 1.76B | -1.77% | 127,781 | - |
| 109 | GENB | Generate Biomedicines, Inc. | 1.73B | -0.66% | 51,226 | 26.48M |
| 110 | NTLA | Intellia Therapeutics, Inc. | 1.72B | 5.04% | 1,008,605 | 59.51M |
| 111 | XNCR | Xencor, Inc. | 1.72B | -4.45% | 201,360 | 104.97M |
| 112 | MESO | Mesoblast Limited | 1.68B | -3.66% | 26,158 | 120.25M |
| 113 | NUVB | Nuvation Bio Inc. | 1.68B | -1.44% | 223,981 | 169.90M |
| 114 | SEPN | Septerna, Inc. | 1.62B | -3.71% | 58,783 | 98.88M |
| 115 | QURE | uniQure N.V. | 1.57B | -2.38% | 84,007 | 18.67M |
| 116 | ABSI | Absci Corporation | 1.56B | -1.41% | 736,532 | 1.56M |
| 117 | OCUL | Ocular Therapeutix, Inc. | 1.56B | -1.80% | 131,453 | 52.06M |
| 118 | STOK | Stoke Therapeutics, Inc. | 1.55B | -1.03% | 16,523 | 27.59M |
| 119 | INVA | Innoviva, Inc. | 1.51B | -0.66% | 12,254 | 440.00M |
| 120 | SNDX | Syndax Pharmaceuticals, Inc. | 1.50B | -1.35% | 60,716 | 252.25M |
| 121 | IMCR | Immunocore Holdings plc | 1.49B | -1.73% | 14,134 | 430.78M |
| 122 | BRVE | Braveheart Bio, Inc. | 1.48B | -2.10% | 11,972 | - |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.46B | -1.17% | 9,348 | 20.00M |
| 124 | GHRS | GH Research PLC | 1.44B | -0.09% | 7,268 | - |
| 125 | KRSA | Korsana Biosciences, Inc. | 1.44B | - | 2,435 | - |
| 126 | RARE | Ultragenyx Pharmaceutical Inc. | 1.44B | -1.54% | 183,133 | 717.00M |
| 127 | MAZE | Maze Therapeutics, Inc. | 1.44B | -1.33% | 6,653 | 20.00M |
| 128 | TSHA | Taysha Gene Therapies, Inc. | 1.44B | -0.56% | 68,879 | 5.49M |
| 129 | NKTR | Nektar Therapeutics | 1.37B | -0.50% | 71,929 | 54.59M |
| 130 | TYRA | Tyra Biosciences, Inc. | 1.37B | -2.50% | 19,069 | - |
| 131 | INBX | Inhibrx Biosciences, Inc. | 1.35B | -1.56% | 17,214 | 1.30M |
| 132 | OMER | Omeros Corporation | 1.35B | -0.69% | 25,185 | 38.42M |
| 133 | ANAB | AnaptysBio, Inc. | 1.35B | -1.36% | 17,418 | 106.09M |
| 134 | COAG | Hemab Therapeutics Holdings, Inc. | 1.33B | -0.59% | 4,245 | - |
| 135 | KLRA | Kailera Therapeutics, Inc. | 1.33B | -2.75% | 74,427 | - |
| 136 | KARD | Kardigan, Inc. | 1.30B | 0.29% | 20,888 | - |
| 137 | DRTS | Alpha Tau Medical Ltd. | 1.29B | -1.75% | 79,359 | - |
| 138 | AAPG | Ascentage Pharma Group International | 1.29B | -1.61% | 8,211 | 94.61M |
| 139 | REPL | Replimune Group, Inc. | 1.26B | 1.59% | 76,547 | - |
| 140 | DMRA | Damora Therapeutics, Inc. | 1.21B | -2.87% | 6,742 | - |
| 141 | ORIC | ORIC Pharmaceuticals, Inc. | 1.21B | -3.08% | 86,500 | - |
| 142 | NBTX | Nanobiotix S.A. | 1.20B | -5.56% | 9,519 | 13.15M |
| 143 | SVRA | Savara Inc. | 1.19B | -3.79% | 106,330 | - |
| 144 | MNKD | MannKind Corporation | 1.13B | 2.03% | 286,122 | 393.63M |
| 145 | AVLN | Avalyn Pharma Inc. | 1.10B | -2.66% | 5,477 | - |
| 146 | TRAX | First Tracks Biotherapeutics, Inc. | 1.09B | - | 136,041 | - |
| 147 | LBRX | LB Pharmaceuticals Inc | 1.08B | -1.64% | 7,442 | - |
| 148 | VOR | Vor Biopharma Inc. | 1.08B | -3.06% | 56,932 | - |
| 149 | JANX | Janux Therapeutics, Inc. | 1.07B | -2.06% | 37,350 | 24.00M |
| 150 | BCAX | Bicara Therapeutics Inc. | 1.06B | -2.56% | 18,445 | - |
| 151 | LTGO | Latigo Biotherapeutics, Inc. | 1.03B | - | 5,285 | - |
| 152 | MGTX | MeiraGTx Holdings plc | 1.03B | -1.20% | 47,424 | 397.50M |
| 153 | IMTX | Immatics N.V. | 991.69M | -2.62% | 18,450 | 47.65M |
| 154 | SPTX | Seaport Therapeutics, Inc. | 988.21M | 2.96% | 3,365 | - |
| 155 | AKTS | Aktis Oncology, Inc. | 978.07M | -2.31% | 10,555 | 10.06M |
| 156 | CGEM | Cullinan Therapeutics, Inc. | 972.40M | -3.33% | 40,636 | - |
| 157 | ANL | Adlai Nortye Group Ltd. | 932.48M | 3.06% | 621,492 | 18.06M |
| 158 | KURA | Kura Oncology, Inc. | 919.85M | -3.09% | 86,684 | 77.23M |
| 159 | MLTX | MoonLake Immunotherapeutics | 903.83M | -1.39% | 40,521 | - |
| 160 | ANRO | Alto Neuroscience, Inc. | 895.50M | -2.98% | 13,746 | - |
| 161 | RIGL | Rigel Pharmaceuticals, Inc. | 878.14M | -2.04% | 4,650 | 276.79M |
| 162 | ALMS | Alumis Inc. | 865.92M | -1.18% | 63,258 | 7.40M |
| 163 | JBIO | Jade Biosciences, Inc. | 858.56M | -1.96% | 14,452 | - |
| 164 | SLBT | SL Science Holding Limited | 855.40M | -0.66% | 4,847 | 3.27M |
| 165 | GLUE | Monte Rosa Therapeutics, Inc. | 843.75M | -2.75% | 43,163 | 28.73M |
| 166 | CRVS | Corvus Pharmaceuticals, Inc. | 842.89M | -3.75% | 140,852 | - |
| 167 | ODTX | Odyssey Therapeutics, Inc. | 830.43M | -4.15% | 16,617 | 99.00K |
| 168 | ABUS | Arbutus Biopharma Corporation | 825.03M | -2.80% | 335,894 | 181.72M |
| 169 | SANA | Sana Biotechnology, Inc. | 808.27M | -0.74% | 284,302 | - |
| 170 | SGP | SpyGlass Pharma, Inc. | 799.41M | - | 6,160 | - |
| 171 | ARDX | Ardelyx, Inc. | 797.40M | -1.84% | 348,722 | 450.89M |
| 172 | AVBP | ArriVent BioPharma, Inc. | 793.36M | -4.74% | 174,891 | - |
| 173 | OBX | Obsidian Therapeutics, Inc. | 787.60M | -3.41% | 10,639 | - |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | 769.77M | -1.70% | 232,871 | 41.47M |
| 175 | HELP | Helus Pharma Inc. | 762.75M | -0.67% | 181,485 | - |
| 176 | GERN | Geron Corporation | 761.33M | -1.25% | 699,637 | 204.56M |
| 177 | IVA | Inventiva S.A. | 758.77M | -3.71% | 115,126 | 2.81M |
| 178 | IMMX | Immix Biopharma, Inc. | 752.76M | -4.32% | 127,620 | - |
| 179 | DNA | Ginkgo Bioworks Holdings, Inc. | 747.48M | -3.23% | 693,720 | 132.42M |
| 180 | ACHV | Achieve Life Sciences, Inc. | 745.53M | 0.07% | 96,311 | - |
| 181 | ATTO | Attovia Therapeutics, Inc. | 743.20M | -0.85% | 12,848 | 1.80M |
| 182 | APMD | Apnimed, Inc. | 741.03M | -1.33% | 24,288 | 115.12M |
| 183 | CADL | Candel Therapeutics, Inc. | 739.17M | -1.63% | 43,999 | - |
| 184 | VSTM | Verastem, Inc. | 739.00M | -1.27% | 139,429 | 87.53M |
| 185 | ANNX | Annexon, Inc. | 733.67M | -3.49% | 109,556 | - |
| 186 | GYRE | Gyre Therapeutics, Inc. | 729.51M | -2.27% | 11,303 | 109.82M |
| 187 | SLDB | Solid Biosciences Inc. | 721.63M | -1.75% | 31,427 | - |
| 188 | DSGN | Design Therapeutics, Inc. | 711.55M | -2.74% | 15,075 | - |
| 189 | AVTX | Avalo Therapeutics, Inc. | 708.45M | -2.72% | 19,042 | 59.00K |
| 190 | PHAR | Pharming Group N.V. | 681.88M | - | 151 | 366.48M |
| 191 | PRME | Prime Medicine, Inc. | 681.37M | -1.79% | 426,983 | 4.07M |
| 192 | FDMT | 4D Molecular Therapeutics, Inc. | 677.29M | -2.62% | 20,080 | 92.01M |
| 193 | WVE | Wave Life Sciences, Inc. | 675.88M | -3.11% | 238,977 | 65.37M |
| 194 | OLMA | Olema Pharmaceuticals, Inc. | 675.48M | -2.77% | 40,340 | - |
| 195 | AURA | Aura Biosciences, Inc. | 672.53M | 0.39% | 69,007 | - |
| 196 | MDXG | MiMedx Group, Inc. | 662.48M | -1.41% | 34,801 | 355.17M |
| 197 | NVCT | Nuvectis Pharma, Inc. | 653.91M | -1.08% | 3,454 | - |
| 198 | ZVRA | Zevra Therapeutics, Inc. | 652.63M | -0.81% | 18,258 | 136.07M |
| 199 | FTH | Faeth Therapeutics, Inc. | 632.96M | -1.71% | 2,037 | - |
| 200 | OABI | OmniAb, Inc. | 628.09M | -5.26% | 67,328 | 38.46M |
| 201 | SGMT | Sagimet Biosciences Inc. | 621.16M | -1.35% | 59,755 | - |
| 202 | CLYM | Climb Bio, Inc. | 596.19M | -3.08% | 30,740 | - |
| 203 | DBVT | DBV Technologies S.A. | 583.97M | -0.72% | 10,671 | 5.04M |
| 204 | ETRA | Electra Therapeutics, Inc. | 578.08M | 0.55% | 10,149 | - |
| 205 | SLN | Silence Therapeutics plc | 566.57M | -4.18% | 60,642 | 615.00K |
| 206 | CBIO | Crescent Biopharma, Inc. | 564.97M | -2.15% | 9,533 | 11.88M |
| 207 | CRMD | CorMedix Inc. | 564.32M | -0.55% | 51,773 | 462.25M |
| 208 | MNPR | Monopar Therapeutics Inc. | 558.25M | -0.73% | 29,273 | - |
| 209 | STTK | Shattuck Labs, Inc. | 552.00M | -2.74% | 75,671 | 1.00M |
| 210 | NGNE | Neurogene Inc. | 537.51M | 3.83% | 29,221 | 925.00K |
| 211 | CTMX | CytomX Therapeutics, Inc. | 536.03M | -3.53% | 196,247 | 18.30M |
| 212 | PHAT | Phathom Pharmaceuticals, Inc. | 533.77M | -1.32% | 17,245 | 239.66M |
| 213 | VALN | Valneva SE | 529.02M | -4.40% | 2,107 | 163.30M |
| 214 | BLSM | BlossomHill Therapeutics, Inc. | 527.63M | -0.06% | 5,737 | - |
| 215 | OCS | Oculis Holding AG | 521.02M | -0.71% | 13,125 | 1.45M |
| 216 | MPLT | MapLight Therapeutics, Inc. | 508.52M | -2.24% | 15,002 | - |
| 217 | ALT | Altimmune, Inc. | 506.72M | -2.07% | 393,098 | 31.00K |
| 218 | EPRX | Eupraxia Pharmaceuticals Inc. | 499.61M | -1.99% | 16,031 | - |
| 219 | PBYI | Puma Biotechnology, Inc. | 498.39M | -1.58% | 12,877 | 231.24M |
| 220 | ACRS | Aclaris Therapeutics, Inc. | 493.85M | -1.32% | 288,864 | 8.22M |
| 221 | DRUG | Bright Minds Biosciences Inc. | 493.62M | -2.96% | 6,520 | - |
| 222 | RGNX | REGENXBIO Inc. | 491.14M | -2.04% | 62,693 | 174.48M |
| 223 | ALLO | Allogene Therapeutics, Inc. | 481.96M | -2.45% | 250,292 | 4.64M |
| 224 | ARVN | Arvinas, Inc. | 477.97M | -1.88% | 67,888 | 316.70M |
| 225 | CTNM | Contineum Therapeutics, Inc. | 475.15M | -0.79% | 16,236 | - |
| 226 | PROK | ProKidney Corp. | 474.65M | - | 73,933 | 818.00K |
| 227 | AUTL | Autolus Therapeutics plc | 465.78M | -3.31% | 206,370 | 117.39M |
| 228 | RZLT | Rezolute, Inc. | 461.55M | 0.46% | 83,287 | - |
| 229 | CAPR | Capricor Therapeutics, Inc. | 458.14M | -2.72% | 280,051 | 11.13M |
| 230 | ASMB | Assembly Biosciences, Inc. | 455.87M | -2.44% | 6,510 | 74.85M |
| 231 | OVID | Ovid Therapeutics Inc. | 452.11M | -1.91% | 89,009 | 1.58M |
| 232 | AGMB | AgomAb Therapeutics NV | 441.26M | 1.82% | 10,405 | - |
| 233 | TECX | Tectonic Therapeutic, Inc. | 434.00M | -2.25% | 13,598 | - |
| 234 | PRTA | Prothena Corporation plc | 430.97M | -1.00% | 11,389 | 54.53M |
| 235 | ENTX | Entera Bio Ltd. | 430.26M | -1.00% | 9,791 | 42.00K |
| 236 | DMAC | DiaMedica Therapeutics Inc. | 426.01M | -1.13% | 5,353 | - |
| 237 | SPRY | ARS Pharmaceuticals, Inc. | 424.64M | -2.06% | 24,462 | 116.93M |
| 238 | YDES | YD Bio Limited | 420.74M | 1.02% | 4,261 | 1.24M |
| 239 | EDIT | Editas Medicine, Inc. | 414.67M | -1.82% | 178,253 | 47.01M |
| 240 | AVIR | Atea Pharmaceuticals, Inc. | 399.42M | -0.60% | 14,621 | - |
| 241 | EIKN | Eikon Therapeutics, Inc. | 397.03M | -2.79% | 94,421 | - |
| 242 | PRLD | Prelude Therapeutics Incorporated | 387.26M | -1.83% | 20,053 | 22.42M |
| 243 | VTVT | vTv Therapeutics Inc. | 382.81M | -0.64% | 2,869 | 36.84M |
| 244 | ZURA | Zura Bio Limited | 382.36M | -4.32% | 52,202 | - |
| 245 | KYTX | Kyverna Therapeutics, Inc. | 373.53M | -2.11% | 50,185 | - |
| 246 | IRD | Opus Genetics, Inc. | 364.40M | -0.68% | 60,149 | 9.86M |
| 247 | FENC | Fennec Pharmaceuticals Inc. | 360.14M | -0.87% | 668 | 59.22M |
| 248 | TTRX | Turn Therapeutics Inc. | 355.67M | -1.32% | 8,383 | - |
| 249 | GALT | Galectin Therapeutics Inc. | 354.99M | -2.76% | 26,122 | - |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 354.16M | -1.70% | 17,099 | 65.26M |
| 251 | IKT | Inhibikase Therapeutics, Inc. | 347.76M | -1.55% | 10,674 | 1.00 |
| 252 | ARCT | Arcturus Therapeutics Holdings Inc. | 343.92M | -5.21% | 36,714 | 29.37M |
| 253 | RLMD | Relmada Therapeutics, Inc. | 339.21M | -2.15% | 39,716 | - |
| 254 | CCCC | C4 Therapeutics, Inc. | 338.32M | -2.48% | 58,015 | 35.04M |
| 255 | AGEN | Agenus Inc. | 334.05M | -1.98% | 73,218 | 132.69M |
| 256 | OCGN | Ocugen, Inc. | 333.04M | -1.79% | 1,418,692 | 4.58M |
| 257 | OBIO | Orchestra BioMed Holdings, Inc. | 331.78M | -2.47% | 14,912 | 31.98M |
| 258 | CABA | Cabaletta Bio, Inc. | 331.46M | -0.76% | 251,305 | - |
| 259 | ARTV | Artiva Biotherapeutics, Inc. | 330.01M | -3.57% | 22,594 | 251.00K |
| 260 | SCTX | Scribe Therapeutics Inc. | 323.73M | -2.68% | 22,989 | 33.30M |
| 261 | INDP | Indaptus Therapeutics, Inc. | 314.45M | 4.42% | 55,852 | - |
| 262 | BNTC | Benitec Biopharma Inc. | 304.88M | -2.78% | 13,296 | - |
| 263 | ABEO | Abeona Therapeutics Inc. | 285.92M | -1.57% | 152,050 | 25.52M |
| 264 | SRZN | Surrozen, Inc. | 283.67M | -4.02% | 30,294 | 11.51M |
| 265 | EYPT | EyePoint, Inc. | 282.78M | -1.20% | 120,241 | 2.79M |
| 266 | LRMR | Larimar Therapeutics, Inc. | 280.79M | -2.18% | 57,852 | - |
| 267 | FULC | Fulcrum Therapeutics, Inc. | 280.77M | 0.27% | 95,960 | 80.00M |
| 268 | RCKT | Rocket Pharmaceuticals, Inc. | 279.93M | 0.59% | 538,188 | - |
| 269 | XFOR | X4 Pharmaceuticals, Inc. | 272.65M | -2.14% | 61,654 | 15.85M |
| 270 | CUVL | Clinuvel Pharmaceuticals Limited | 271.14M | -2.59% | 675 | 65.05M |
| 271 | VNDA | Vanda Pharmaceuticals Inc. | 270.57M | -1.86% | 34,791 | 215.72M |
| 272 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 266.98M | -3.20% | 22,078 | - |
| 273 | LXEO | Lexeo Therapeutics, Inc. | 265.00M | -2.42% | 47,732 | - |
| 274 | SABS | SAB Biotherapeutics, Inc. | 259.31M | -1.04% | 69,581 | 114.70K |
| 275 | BCYC | Bicycle Therapeutics plc | 256.87M | -1.61% | 22,870 | 61.21M |
| 276 | ACIU | AC Immune SA | 251.55M | -1.56% | 6,351 | 21.67M |
| 277 | PALI | Palisade Bio, Inc. | 250.95M | -2.70% | 105,492 | 500.00K |
| 278 | FATE | Fate Therapeutics, Inc. | 248.03M | -3.72% | 157,914 | 6.49M |
| 279 | VCRE | Vicore Pharma Holding AB (publ) | 247.89M | 1.15% | 1,455 | 412.09K |
| 280 | NAUT | Nautilus Biotechnology, Inc. | 246.88M | -1.02% | 1,248,209 | 190.00K |
| 281 | STRO | Sutro Biopharma, Inc. | 242.75M | -0.14% | 38,563 | 45.70M |
| 282 | UPB | Upstream Bio, Inc. | 242.09M | -4.12% | 66,598 | 3.16M |
| 283 | IMRX | Immuneering Corporation | 241.97M | -3.11% | 45,407 | - |
| 284 | LCTX | Lineage Cell Therapeutics, Inc. | 238.86M | -0.33% | 33,708 | 13.08M |
| 285 | SLGL | Sol-Gel Technologies Ltd. | 235.55M | - | 9,835 | 1.80M |
| 286 | ZNTL | Zentalis Pharmaceuticals, Inc. | 234.79M | -2.75% | 53,783 | 26.87M |
| 287 | QTTB | Q32 Bio Inc. | 230.71M | -3.00% | 20,411 | 53.74M |
| 288 | CAMP | Camp4 Therapeutics Corporation | 230.30M | -4.43% | 18,135 | 4.22M |
| 289 | VOGX | Vogenx, Inc. | 230.25M | -4.08% | 5,098 | - |
| 290 | PYXS | Pyxis Oncology, Inc. | 229.36M | -4.48% | 114,679 | 11.04M |
| 291 | EVMN | Evommune, Inc. | 224.65M | -0.48% | 28,490 | 10.00M |
| 292 | PRQR | ProQR Therapeutics N.V. | 224.38M | -2.45% | 106,986 | 21.05M |
| 293 | IFRX | InflaRx N.V. | 224.00M | -2.56% | 30,823 | -11.54K |
| 294 | MGNX | MacroGenics, Inc. | 223.59M | -1.13% | 8,486 | 175.14M |
| 295 | IPSC | Century Therapeutics, Inc. | 222.72M | -3.91% | 313,012 | 109.16M |
| 296 | GLSI | Greenwich LifeSciences, Inc. | 220.91M | -2.21% | 2,947 | - |
| 297 | KROS | Keros Therapeutics, Inc. | 219.09M | -1.43% | 6,695 | 15.01M |
| 298 | ALEC | Alector, Inc. | 214.94M | 0.26% | 238,331 | 13.86M |
| 299 | PLX | Protalix BioTherapeutics, Inc. | 213.51M | -2.21% | 160,175 | 80.62M |
| 300 | SION | Sionna Therapeutics, Inc. | 212.95M | -2.28% | 21,030 | - |
| 301 | IVVD | Invivyd, Inc. | 207.16M | -3.54% | 913,468 | 58.37M |
| 302 | LYEL | Lyell Immunopharma, Inc. | 203.64M | -2.92% | 3,903 | 27.00K |
| 303 | CGEN | Compugen Ltd. | 198.92M | -2.33% | 19,748 | 74.00M |
| 304 | RNAC | Cartesian Therapeutics, Inc. | 197.26M | -2.40% | 16,683 | 1.48M |
| 305 | ACOG | Alpha Cognition Inc. | 196.44M | -0.22% | 180 | 15.26M |
| 306 | ELDN | Eledon Pharmaceuticals, Inc. | 192.78M | -2.07% | 56,261 | - |
| 307 | WHWK | Whitehawk Therapeutics, Inc. | 192.12M | -1.17% | 7,831 | 7.15M |
| 308 | TRDA | Entrada Therapeutics, Inc. | 191.36M | -5.40% | 10,834 | 4.69M |
| 309 | ADAG | Adagene Inc. | 189.34M | 0.36% | 7,670 | 9.29M |
| 310 | NGEN | NervGen Pharma Corp. | 189.24M | 1.15% | 32,570 | - |
| 311 | ANTX | AN2 Therapeutics, Inc. | 179.81M | -1.75% | 5,664 | - |
| 312 | CMPX | Compass Therapeutics, Inc. | 177.98M | -3.11% | 264,716 | 850.00K |
| 313 | ORMP | Oramed Pharmaceuticals Inc. | 177.20M | -2.52% | 49,851 | 2.00M |
| 314 | CNTN | Canton Strategic Holdings, Inc. | 174.90M | -2.88% | 88,783 | 1.50M |
| 315 | DTIL | Precision BioSciences, Inc. | 173.34M | 0.48% | 29,863 | 45.06M |
| 316 | YARW | Yarrow Bioscience, Inc. | 173.15M | -0.88% | 3,040 | - |
| 317 | VRXA | Veraxa Biotech AG | 169.69M | - | 16,553 | 29.54K |
| 318 | MSLE | Satellos Bioscience Inc. | 166.02M | 0.26% | 2,271 | - |
| 319 | MDWD | MediWound Ltd. | 165.25M | -0.39% | 2,181 | 11.86M |
| 320 | PEPG | PepGen Inc. | 161.37M | -2.92% | 26,396 | - |
| 321 | NKTX | Nkarta, Inc. | 158.29M | -2.64% | 40,874 | - |
| 322 | CUE | Cue Biopharma, Inc. | 157.86M | -3.47% | 14,721 | 37.66M |
| 323 | NBP | NovaBridge Biosciences | 156.60M | -1.46% | 15,859 | - |
| 324 | CHRS | Coherus Oncology, Inc. | 156.05M | - | 109,259 | 50.94M |
| 325 | NERV | Minerva Neurosciences, Inc. | 155.18M | -0.61% | 698 | - |
| 326 | KRRO | Korro Bio, Inc. | 153.29M | -0.76% | 11,219 | 2.38M |
| 327 | MOLN | Molecular Partners AG | 153.02M | - | 1 | 856.30K |
| 328 | MENS | Jyong Biotech Ltd. | 152.92M | - | 2,519 | - |
| 329 | TARA | Protara Therapeutics, Inc. | 151.28M | -1.16% | 45,159 | - |
| 330 | CDXS | Codexis, Inc. | 150.02M | -2.84% | 83,217 | 77.68M |
| 331 | ALXO | ALX Oncology Holdings Inc. | 149.34M | -4.42% | 83,423 | - |
| 332 | ABOS | Acumen Pharmaceuticals, Inc. | 148.25M | -2.38% | 52,645 | - |
| 333 | VYGR | Voyager Therapeutics, Inc. | 147.27M | -3.24% | 40,167 | 34.46M |
| 334 | TLSA | Tiziana Life Sciences Ltd | 143.53M | 0.91% | 56,717 | - |
| 335 | ARMP | Armata Pharmaceuticals, Inc. | 140.92M | -0.52% | 1,112 | 5.54M |
| 336 | OTLK | Outlook Therapeutics, Inc. | 140.15M | -2.42% | 250,843 | -1.16M |
| 337 | AVXL | Anavex Life Sciences Corp. | 139.97M | -1.31% | 49,402 | - |
| 338 | RNA | Atrium Therapeutics, Inc. | 138.90M | 2.40% | 123,225 | 35.84M |
| 339 | IPHA | Innate Pharma S.A. | 136.02M | -0.99% | 977 | 11.21M |
| 340 | TNXP | Tonix Pharmaceuticals Holding Corp. | 128.29M | -0.93% | 40,038 | 29.10M |
| 341 | KZIA | Kazia Therapeutics Limited | 126.07M | -0.97% | 3,808 | 1.27M |
| 342 | SPRB | Spruce Biosciences, Inc. | 125.45M | -1.69% | 4,424 | 697.00K |
| 343 | HUMA | Humacyte, Inc. | 125.18M | -4.59% | 646,241 | 2.12M |
| 344 | HURA | TuHURA Biosciences, Inc. | 123.95M | -1.77% | 22,372 | - |
| 345 | CBUS | Cibus, Inc. | 123.81M | - | 4,069 | 4.35M |
| 346 | NRXP | NRx Pharmaceuticals, Inc. | 122.43M | -2.41% | 35,094 | 3.39M |
| 347 | SEER | Seer, Inc. | 122.37M | - | 7,346 | 14.22M |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 117.72M | -1.57% | 298,471 | 1.34M |
| 349 | INO | Inovio Pharmaceuticals, Inc. | 117.36M | -1.73% | 253,122 | 65.34K |
| 350 | RANI | Rani Therapeutics Holdings, Inc. | 116.53M | 2.94% | 13,172 | 4.88M |
| 351 | FHTX | Foghorn Therapeutics Inc. | 114.61M | -7.66% | 84,857 | 36.74M |
| 352 | ENGN | enGene Therapeutics Inc. | 114.60M | -2.01% | 52,817 | - |
| 353 | VANI | Vivani Medical, Inc. | 113.66M | -0.79% | 8,379 | - |
| 354 | UNCY | Unicycive Therapeutics, Inc. | 113.65M | -2.39% | 136,054 | - |
| 355 | PMVP | PMV Pharmaceuticals, Inc. | 113.27M | - | 33,066 | - |
| 356 | COYA | Coya Therapeutics, Inc. | 112.13M | -2.65% | 10,110 | 8.02M |
| 357 | LENZ | LENZ Therapeutics, Inc. | 111.55M | -1.93% | 14,354 | 21.48M |
| 358 | GNLX | Genelux Corporation | 109.79M | -2.78% | 33,273 | 8.00K |
| 359 | TENX | Tenax Therapeutics, Inc. | 105.97M | -3.14% | 263,101 | - |
| 360 | TVGN | Tevogen Inc. | 105.12M | 2.93% | 310 | - |
| 361 | PLYX | Polaryx Therapeutics, Inc. | 104.18M | - | 38 | - |
| 362 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 104.06M | -2.00% | 226,681 | - |
| 363 | AARD | Aardvark Therapeutics, Inc. | 103.08M | -5.04% | 22,336 | - |
| 364 | MIST | Milestone Pharmaceuticals Inc. | 102.48M | -3.95% | 104,270 | 2.34M |
| 365 | BDTX | Black Diamond Therapeutics, Inc. | 102.27M | -2.73% | 114,387 | 70.00M |
| 366 | ANIX | Anixa Biosciences, Inc. | 101.68M | -0.85% | 15,051 | - |
| 367 | IMUX | Immunic, Inc. | 100.01M | -3.93% | 36,995 | - |
| 368 | CNXU | Conexeu Sciences Inc. | 98.72M | -3.85% | 26,929 | - |
| 369 | PYPD | PolyPid Ltd. | 96.89M | -3.64% | 7,802 | - |
| 370 | BMEA | Biomea Fusion, Inc. | 95.68M | - | 39,563 | - |
| 371 | CLLS | Cellectis S.A. | 95.44M | -4.48% | 14,799 | 63.82M |
| 372 | ATRA | Atara Biotherapeutics, Inc. | 94.56M | 0.53% | 1,973 | 6.19M |
| 373 | OKUR | OnKure Therapeutics, Inc. | 91.12M | -4.26% | 9,078 | - |
| 374 | CGTX | Cognition Therapeutics, Inc. | 89.39M | 0.36% | 11,405 | - |
| 375 | RLYB | Rallybio Corporation | 88.95M | -1.06% | 486 | 646.00K |
| 376 | ICCC | ImmuCell Corporation | 88.46M | 0.52% | 136 | 30.68M |
| 377 | PTHS | Pelthos Therapeutics Inc. | 87.86M | 9.34% | 6,208 | 43.30M |
| 378 | EQ | Equillium, Inc. | 87.50M | -0.72% | 48,695 | 4.39M |
| 379 | NMRA | Neumora Therapeutics, Inc. | 86.15M | -2.09% | 119,396 | - |
| 380 | NRXS | NeurAxis, Inc. | 85.77M | - | 5,863 | 5.32M |
| 381 | CRDF | Cardiff Oncology, Inc. | 81.69M | -3.67% | 72,683 | 508.00K |
| 382 | NTRB | Nutriband Inc. | 79.01M | -3.77% | 456 | 1.62M |
| 383 | PMN | ProMIS Neurosciences, Inc. | 78.74M | -3.73% | 8,031 | - |
| 384 | TELO | Telomir Pharmaceuticals, Inc. | 78.40M | 1.79% | 22,442 | - |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 77.99M | -3.19% | 35,930 | - |
| 386 | MNOV | MediciNova, Inc. | 77.28M | -2.48% | 31,965 | 920.48K |
| 387 | OKYO | OKYO Pharma Limited | 74.78M | 1.06% | 2,432 | - |
| 388 | ONCY | Oncolytics Biotech Inc. | 74.25M | -2.27% | 30,405 | - |
| 389 | OSTX | OS Therapies Incorporated | 73.34M | 2.58% | 60,796 | - |
| 390 | PDSB | PDS Biotechnology Corporation | 73.20M | -5.16% | 728,845 | - |
| 391 | GANX | Gain Therapeutics, Inc. | 71.58M | -1.80% | 38,947 | - |
| 392 | VRCA | Verrica Pharmaceuticals Inc. | 71.12M | - | 454 | 30.32M |
| 393 | HRTX | Heron Therapeutics, Inc. | 70.91M | -2.81% | 196,422 | 151.18M |
| 394 | CING | Cingulate Inc. | 70.89M | 0.10% | 900 | - |
| 395 | SPRO | Spero Therapeutics, Inc. | 69.91M | 2.61% | 172,830 | 47.00M |
| 396 | HYFT | MindWalk Holdings Corp. | 69.73M | -1.33% | 26,932 | 11.57M |
| 397 | MAIA | MAIA Biotechnology, Inc. | 69.34M | -3.39% | 190,883 | - |
| 398 | FBIO | Fortress Biotech, Inc. | 68.04M | - | 16,971 | 68.47M |
| 399 | CSBR | Champions Oncology, Inc. | 67.92M | - | 5 | 60.66M |
| 400 | NTHI | NeOnc Technologies Holdings, Inc. | 67.36M | - | 8,242 | 39.99K |
| 401 | XBIT | XBiotech Inc. | 67.07M | 0.46% | 4,207 | - |
| 402 | ACET | Adicet Bio, Inc. | 65.23M | -1.94% | 31,760 | - |
| 403 | RNTX | Rein Therapeutics Inc. | 65.13M | -4.27% | 24,304 | - |
| 404 | IBIO | iBio, Inc. | 62.20M | -4.24% | 39,130 | 100.00K |
| 405 | GOSS | Gossamer Bio, Inc. | 61.72M | -0.79% | 20,910 | 53.29M |
| 406 | PLRX | Pliant Therapeutics, Inc. | 61.30M | - | 26,950 | - |
| 407 | KLRS | Kalaris Therapeutics, Inc. | 60.94M | - | 56 | - |
| 408 | RNXT | RenovoRx, Inc. | 60.92M | -1.46% | 38,079 | 1.98M |
| 409 | BOLD | Boundless Bio, Inc. | 60.51M | 0.76% | 15,104 | - |
| 410 | ELOX | Eloxx Pharmaceuticals, Inc. | 60.30M | 0.40% | 562 | - |
| 411 | XLO | Xilio Therapeutics, Inc. | 59.29M | - | 513 | 64.09M |
| 412 | GUTS | Fractyl Health, Inc. | 58.90M | -1.77% | 22,236 | 3.00K |
| 413 | CRBU | Caribou Biosciences, Inc. | 58.87M | -11.06% | 3,194,017 | 10.04M |
| 414 | CNTB | Connect Biopharma Holdings Limited | 58.57M | -1.56% | 66,960 | 2.95M |
| 415 | INKT | MiNK Therapeutics, Inc. | 58.43M | 0.26% | 647 | - |
| 416 | MREO | Mereo BioPharma Group plc | 58.13M | 3.17% | 246,606 | 500.00K |
| 417 | ALDX | Aldeyra Therapeutics, Inc. | 56.96M | -1.51% | 27,617 | - |
| 418 | ATHE | Alterity Therapeutics Limited | 56.95M | -6.02% | 913 | 2.50M |
| 419 | ALPS | Alps Group Inc | 56.58M | -1.28% | 372 | 3.74M |
| 420 | CLNN | Clene Inc. | 54.58M | -2.04% | 5,598 | 197.00K |
| 421 | LONA | LeonaBio, Inc. | 54.46M | -0.86% | 3,085 | - |
| 422 | EDSA | Edesa Biotech, Inc. | 53.51M | 1.67% | 23,292 | - |
| 423 | HYPD | Hyperion DeFi, Inc. | 52.83M | -5.29% | 42,474 | 1.40M |
| 424 | IMA | ImageneBio, Inc. | 52.33M | - | 74 | 800.00K |
| 425 | EXOZ | eXoZymes, Inc. | 51.42M | - | 34 | -700.00 |
| 426 | SER | Serina Therapeutics, Inc. | 51.31M | 0.50% | 5,517 | 130.00K |
| 427 | INMB | INmune Bio Inc. | 51.07M | -1.08% | 17,412 | 50.00K |
| 428 | ANVS | Annovis Bio, Inc. | 49.00M | -4.96% | 112,992 | - |
| 429 | CRVO | CervoMed Inc. | 48.99M | 1.89% | 23,813 | 331.30K |
| 430 | DWTX | Dogwood Therapeutics, Inc. | 48.95M | 0.70% | 11,571 | - |
| 431 | CELU | Celularity Inc. | 47.70M | - | 3,495 | 18.97M |
| 432 | APLM | Apollomics, Inc. | 47.22M | - | 106 | 8.84M |
| 433 | ELTX | Elicio Therapeutics, Inc. | 46.52M | -4.32% | 16,167 | - |
| 434 | TIL | Instil Bio, Inc. | 46.39M | -0.87% | 3,637 | - |
| 435 | HOWL | Werewolf Therapeutics, Inc. | 44.71M | -0.02% | 9,304 | 21.00M |
| 436 | BSEM | BioStem Technologies, Inc. | 44.60M | 0.42% | 13,568 | 34.59M |
| 437 | GRCE | Grace Therapeutics, Inc. | 43.12M | -2.38% | 1,626 | - |
| 438 | VERU | Veru Inc. | 41.77M | -0.41% | 10,570 | 16.89M |
| 439 | IBO | Impact BioMedical Inc. | 38.28M | - | 983 | 35.00K |
| 440 | FLNA | Filana Therapeutics, Inc. | 38.16M | -3.15% | 21,805 | - |
| 441 | CVM | CEL-SCI Corporation | 37.82M | 0.94% | 46,420 | - |
| 442 | MGX | Metagenomi Therapeutics, Inc. | 37.59M | 1.05% | 23,863 | 13.56M |
| 443 | LITS | Lite Strategy, Inc. | 37.10M | -3.94% | 273,951 | - |
| 444 | NNVC | NanoViricides, Inc. | 34.71M | -5.56% | 60,674 | - |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 34.59M | 2.80% | 3,833 | 35.09M |
| 446 | BCTX | BriaCell Therapeutics Corp. | 34.28M | -1.25% | 1,493 | - |
| 447 | ALGS | Aligos Therapeutics, Inc. | 32.35M | -2.63% | 2,329 | 31.52M |
| 448 | GRDX | GridAI Technologies Corp. | 30.73M | 5.34% | 2,652 | - |
| 449 | RNAZ | TransCode Therapeutics, Inc. | 30.48M | 2.27% | 4,170 | - |
| 450 | IGC | IGC Pharma, Inc. | 28.95M | - | 17,829 | 1.11M |
| 451 | NXTC | NextCure, Inc. | 28.79M | -4.12% | 6,465 | - |
| 452 | CNTX | Context Therapeutics Inc. | 28.57M | -0.54% | 18,077 | - |
| 453 | IMMP | Immutep Limited | 28.37M | -1.23% | 2,020 | 13.79M |
| 454 | QNCX | Quince Therapeutics, Inc. | 27.56M | 1.40% | 471 | - |
| 455 | MCRB | Seres Therapeutics, Inc. | 27.22M | -0.37% | 3,271 | 1.88M |
| 456 | ABVC | ABVC BioPharma, Inc. | 27.22M | 5.00% | 1,343 | 797.92K |
| 457 | EVAX | Evaxion A/S | 26.55M | 0.72% | 1,979 | 7.49M |
| 458 | ATYR | aTyr Pharma, Inc. | 26.13M | -4.28% | 217,238 | 190.00K |
| 459 | BYSI | BeyondSpring Inc. | 25.74M | -2.87% | 6,486 | 1.88M |
| 460 | QNTM | Quantum BioPharma Ltd. | 25.19M | -0.95% | 7,974 | - |
| 461 | KYNB | Kyntra Bio, Inc. | 24.90M | 0.33% | 192 | 4.62M |
| 462 | ATOS | Atossa Therapeutics, Inc. | 24.63M | 0.32% | 8,922 | - |
| 463 | PLRZ | Polyrizon Ltd. | 23.92M | 7.65% | 1,159 | - |
| 464 | QNRX | Quoin Pharmaceuticals, Ltd. | 21.57M | -4.47% | 639 | - |
| 465 | COCP | Cocrystal Pharma, Inc. | 20.42M | 0.01% | 9,967 | 330.00K |
| 466 | AKTX | Akari Therapeutics, Plc | 19.68M | -0.17% | 2,862 | - |
| 467 | PBM | Psyence Biomedical Ltd. | 19.38M | 4.10% | 2,771 | - |
| 468 | JSPR | Jasper Therapeutics, Inc. | 18.72M | -1.25% | 4,195 | - |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 18.40M | -0.58% | 303 | 1.17M |
| 470 | PTN | Palatin Technologies, Inc. | 18.08M | 3.57% | 3,320 | 13.19M |
| 471 | ESLA | Estrella Immunopharma, Inc. | 17.88M | -1.98% | 788 | - |
| 472 | TCRX | TScan Therapeutics, Inc. | 17.56M | -6.43% | 25,927 | 7.11M |
| 473 | NCEL | NewcelX Ltd. | 17.53M | - | 10 | - |
| 474 | MRKR | Marker Therapeutics, Inc. | 17.51M | 0.96% | 7,913 | 3.55M |
| 475 | DYAI | Dyadic International, Inc. | 16.76M | 0.77% | 18,522 | 3.80M |
| 476 | BCDA | BioCardia, Inc. | 16.20M | -1.83% | 29,227 | 3.00K |
| 477 | LPCN | Lipocine Inc. | 16.16M | -10.91% | 1,268,027 | 1.57M |
| 478 | KPRX | Kiora Pharmaceuticals, Inc. | 16.04M | -0.40% | 1,784 | 20.00K |
| 479 | RADX | Radiopharm Theranostics Limited | 16.03M | -3.48% | 92 | 8.90M |
| 480 | AEON | AEON Biopharma, Inc. | 15.65M | 0.79% | 146,488 | - |
| 481 | ALLR | Allarity Therapeutics, Inc. | 15.59M | -0.41% | 316 | 345.00K |
| 482 | KTTA | Pasithea Therapeutics Corp. | 15.57M | 5.10% | 3,744 | - |
| 483 | ICU | SeaStar Medical Holding Corporation | 15.29M | -6.72% | 91,692 | 1.71M |
| 484 | ACTU | Actuate Therapeutics, Inc. | 15.20M | -12.59% | 59,874 | - |
| 485 | TVRD | Tvardi Therapeutics, Inc. | 14.47M | -1.36% | 2,085 | - |
| 486 | HIND | Vyome Holdings, Inc. | 14.32M | - | 4,772 | 129.73K |
| 487 | CLRB | Cellectar Biosciences, Inc. | 13.99M | -1.99% | 3,700 | - |
| 488 | KPTI | Karyopharm Therapeutics Inc. | 13.87M | -5.19% | 39,302 | 146.62M |
| 489 | INAB | IN8bio, Inc. | 13.80M | - | 818 | - |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 13.78M | 0.14% | 34,577 | 7.11M |
| 491 | NIKI | Niki BioSolutions, Inc. | 13.52M | -1.08% | 293 | - |
| 492 | TPST | Tempest Therapeutics, Inc. | 12.74M | -2.70% | 19,941 | - |
| 493 | PLUR | Pluri Inc. | 12.47M | -2.88% | 195 | 1.02M |
| 494 | INTS | Intensity Therapeutics, Inc. | 12.41M | - | 344 | - |
| 495 | CNSY | Cerenome, Inc. | 12.37M | -0.31% | 8,605 | 4.20M |
| 496 | BLRX | BioLineRx Ltd. | 12.23M | 4.76% | 4,086 | 1.39M |
| 497 | DARE | Daré Bioscience, Inc. | 11.96M | -1.00% | 36,403 | 1.37M |
| 498 | PASG | Passage Bio, Inc. | 11.91M | -4.02% | 3,897 | - |
| 499 | LTRN | Lantern Pharma Inc. | 11.51M | -1.10% | 20,737 | - |
| 500 | PHIO | Phio Pharmaceuticals Corp. | 11.44M | -1.48% | 3,995 | - |